PolyPid Ltd. financial data

Symbol
PYPD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
18 Hasivim Street, Petach Tikva, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Feb 26, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.2M shares +516%
Common Stock, Shares, Outstanding 10.2M shares +516%
Weighted Average Number of Shares Outstanding, Basic 5.02M shares +240%
Weighted Average Number of Shares Outstanding, Diluted 5.02M shares +240%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.76M USD +20.2%
General and Administrative Expense 1.1M USD -27.1%
Operating Income (Loss) -6.12M USD -5.17%
Nonoperating Income (Expense) -171K USD -2343%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.29M USD -7.98%
Income Tax Expense (Benefit) 2K USD -80%
Net Income (Loss) Attributable to Parent -6.29M USD -7.83%
Earnings Per Share, Basic 1.25 USD/shares -68.4%
Earnings Per Share, Diluted 1.25 USD/shares -68.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.6M USD +195%
Cash, Cash Equivalents, and Short-term Investments 9.35M USD -38.1%
Assets, Current 16.6M USD +173%
Property, Plant and Equipment, Net 6.08M USD -20.3%
Operating Lease, Right-of-Use Asset 2.3M USD +43.7%
Other Assets, Noncurrent 277K USD +218%
Assets 25.2M USD +64.1%
Employee-related Liabilities, Current 1.08M USD +12.6%
Accrued Liabilities, Current 1.46M USD +47.1%
Liabilities, Current 12.7M USD +74%
Long-term Debt and Lease Obligation 6.38M USD -15.8%
Contract with Customer, Liability, Noncurrent 2.55M USD 0%
Operating Lease, Liability, Noncurrent 1.28M USD +49%
Other Liabilities, Noncurrent 396K USD -0.5%
Retained Earnings (Accumulated Deficit) -267M USD -12.2%
Stockholders' Equity Attributable to Parent 7.68M USD
Liabilities and Equity 25.2M USD +64.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 108M shares 0%
Common Stock, Shares, Issued 10.2M shares +516%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 15.8M USD +178%
Deferred Tax Assets, Valuation Allowance 50.2M USD +13.1%
Deferred Tax Assets, Gross 50.7M USD +13.5%
Operating Lease, Liability 2.2M USD +57.2%
Lessee, Operating Lease, Liability, to be Paid 2.45M USD +57.1%
Property, Plant and Equipment, Gross 15.5M USD +0.49%
Operating Lease, Liability, Current 919K USD +70.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 966K USD +133%
Lessee, Operating Lease, Liability, to be Paid, Year One 999K USD +70.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +23.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 253K USD +56.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 484K USD +29.4%
Deferred Tax Assets, Operating Loss Carryforwards 45.8M USD +14%
Lessee, Operating Lease, Liability, to be Paid, Year Four 184K USD
Additional Paid in Capital 236M USD +7.24%
Operating Leases, Future Minimum Payments, Due in Two Years 358K USD
Operating Leases, Future Minimum Payments Due, Next Twelve Months 403K USD
Deferred Tax Assets, Net of Valuation Allowance 528K USD +56.2%
Operating Leases, Future Minimum Payments, Due in Three Years 349K USD
Operating Leases, Future Minimum Payments Due 1.57M USD